Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 28 % of short-term debt in 2025; threshold 65 %.
-
Busy address KBO
27 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Precision for Medicine (BEL) from Sint-Joost-ten-Node, company number BE0764663668, closed financial year 2025 with a result of € 40,673 after tax. For that financial year Precision for Medicine (BEL) recorded a gross margin of € 754,459 and equity of € -712,904. Compared with financial year 2024, the result moved from € -193,730 to € 40,673. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 1, 2026.
€ -712,904
▲ € 40,673 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 40,673
▲ still € 193,730 loss in 2024
Profit after tax over the fiscal year.
€ 287,306
▲ 44% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -722,904.
People and assets in 2025
€ 732,483
▲ 59% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 11,621
▲ 175% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 9,264
▲ 18% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 101,384
▼ 23% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 762,398 | € 659,668 | € 257,972 | € 754,459 | ▲ 192% |
| Profit after taxes | € 53,620 | € -254,901 | € -193,730 | € 40,673 | ▲ € 234,404 |
| Equity | € -304,946 | € -559,847 | € -753,577 | € -712,904 | ▲ € 40,673 |
| Total debts | € 1,253,010 | € 1,414,747 | € 983,461 | € 1,014,901 | ▲ 3% |
| Cash | € 46,731 | € 685,926 | € 199,905 | € 287,306 | ▲ 44% |
| Retained profit | € -314,946 | € -569,847 | € -763,577 | € -722,904 | ▲ € 40,673 |
| Balance sheet total | € 948,065 | € 854,900 | € 229,884 | € 301,997 | ▲ 31% |
| Employees (FTE) | - | 4.1 | - | - |
Key figures of Precision for Medicine (BEL), fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Precision for Medicine (BEL)?
What happened at Precision for Medicine (BEL) in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Karl DEONANAN stepped down as director. NBB
- Stacey HANNA stepped down as director. NBB
- Matthew DEZEE stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 40,673. Source: NBB ↗
- Krzysztof MAZUREK stepped down as director. NBB
- Karl DEONANAN became a director. NBB
- Stacey HANNA became a director. NBB
- Krzysztof MAZUREK became a director. NBB
In short
From € 53,620 profit in 2022 to € 40,673 profit in 2025.
Best year ever: 2022, with € 53,620 profit.
On average € 160,900 of value added per employee in 2023.
A new publication or filing at Precision for Medicine (BEL)? We notify you, reason included.
Follow Precision for Medicine (BEL)Databakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2025 annual accounts
since 2021 · until 2025
Matthew DEZEE
Director
since 2021 · until 2027
Stacey HANNA
Director
since 2024 · until 2030
Karl DEONANAN
Director
since 2025 · until 2031
Establishments
Establishment units
Physical locations of this company
Sint-Lazaruslaan 4/10
1210 Sint-Joost-ten-Node
Sint-Lazaruslaan 4 box 10
1210 Sint-Joost-ten-Node
Active since 4 March 2021
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 27 companies are registered at this address.
All companies at this address →QUICK RESTAURANTS
€ 6 million revenue · 2025
FUBON ELLIPSE( BELGIUM)
€ 29,146 revenue · 2025
FORS MANAGEMENT
€ -17,803 gross margin · 2025
TATA COMMUNICATIONS (BELGIUM)
€ 88,412 gross margin · 2026
IMMO DE MEEUS
€ 3.2 million revenue · 2025
+22 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0764.663.668
- VAT number
- BE 0764.663.668
- Registered office
- Sint-Lazaruslaan 4/10, 1210 Sint-Joost-ten-Node
- Names & denominations
- Precision for Medicine (BEL)
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 4 March 2021
- Peppol
- Active · Active since 27 Mar 2026
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied